Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options

Oncology Research and Treatment
Marit AhrensIAG-N Interdisciplinary Working Group Kidney Cancer of the German Cancer Society

Abstract

Non-clear cell renal cell carcinomas (nccRCC) are rare diseases with heterogeneous histopathologically and genetically defined entities. The clinical data on optimal systemic treatments of nccRCC is rather limited. In this review, the current World Health Organization (WHO) classification of nccRCC based on histopathologic and genetic findings is reported. Regarding systemic treatment options, the most commonly used agents are mTOR inhibitors like everolimus or temsirolimus, or tyrosine kinase inhibitors like sunitinib. 2 small randomized clinical trials with nccRCC comparing sunitinib with everolimus revealed a trend towards a better progression-free survival (PFS) and overall survival (OS) in favor of sunitinib. In RCC with predominant sarcomatoid features, both chemotherapy and targeted agents are reported without any preference for outcome. For subsequent lines of therapy, some case reports describe promising effects of PD-1 or PD-L1 inhibitors in nccRCC including sarcomatoid subtype and Bellini duct carcinoma. Currently, nccRCCs are treated similarly to clear cell RCC or, whenever possible, within clinical trials. Clinical trials with immune checkpoint inhibitors are ongoing.

References

Jan 1, 1995·Genes, Chromosomes & Cancer·M SchoenbergD Sidransky
Mar 1, 1994·The Journal of Urology·B ZbarW M Linehan
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerVictor Reuter
Nov 14, 2002·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Xavier LeroyMarie-Christine Copin
Feb 14, 2003·Oncogene·Ken YamazakiSetsuo Hirohashi
Feb 25, 2003·The American Journal of Pathology·John P T HigginsJames D Brooks
Jun 7, 2006·The Journal of Urology·Noriaki TokudaUNKNOWN Japanese Society of Renal Cancer
Jun 1, 2007·The New England Journal of Medicine·Gary HudesUNKNOWN Global ARCC Trial
Jan 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Toni K ChoueiriBernard Escudier
Mar 28, 2008·Urologic Oncology·Tobias KlatteAllan J Pantuck
Sep 11, 2008·BJU International·Matthias WaldertMesut Remzi
Jun 6, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·John R Srigley, Brett Delahunt
Oct 20, 2009·The Journal of Urology·Jonathan L WrightDaniel W Lin
Nov 3, 2011·BJU International·Alessandro VolpeUNKNOWN Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation
Nov 28, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y KohS-H Lee
May 2, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·W Marston Linehan, Tracey A Rouault
Jul 3, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M R MatranaN M Tannir
Jan 25, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M H VossR J Motzer
Mar 7, 2014·Seminars in Interventional Radiology·Carole A RidgeDavid C Madoff
Jun 3, 2014·European Urology·Francisco E Vera-BadilloEitan Amir
Jul 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerJennifer J Knox
Aug 27, 2014·Cancer Cell·Caleb F DavisChad J Creighton
Sep 7, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T K ChoueiriS Signoretti
Sep 12, 2014·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Giorgio GandagliaMaxine Sun
Nov 18, 2014·Nature Genetics·Steffen DurinckSomasekar Seshagiri
Nov 5, 2015·The New England Journal of Medicine·W Marston LinehanUNKNOWN Cancer Genome Atlas Research Network
Sep 30, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Bernard EscudierLaurence Albiges
Jan 22, 2017·Clinical Genitourinary Cancer·Sebastiano ButiOrazio Caffo
Jun 1, 2017·Clinical Genitourinary Cancer·Maria I CarloChung-Han Lee
Jun 25, 2017·Clinical Genitourinary Cancer·Ruben RaychaudhuriDeepak Kilari
Jul 5, 2017·Clinical Genitourinary Cancer·Keren RouvinovWilmosh Mermershtain
Sep 6, 2017·Clinical Genitourinary Cancer·Abhishek MaitiAmishi Y Shah

❮ Previous
Next ❯

Citations

Sep 10, 2019·International Journal of Cancer. Journal International Du Cancer·Michael StaehlerUNKNOWN RCC-Registry Group (Tumour Registry of Advanced Renal Cell Carcinoma)
Apr 25, 2019·International Journal of Molecular Sciences·Cristina GrangeBenedetta Bussolati
May 21, 2021·Cancer Treatment Reviews·Philippe BarthélémySylvie Négrier
Jul 3, 2021·International Journal of Molecular Sciences·Andrea MarchettiFrancesco Massari
Jul 23, 2021·Expert Review of Anticancer Therapy·Lothar BergmannMarit Ahrens
Sep 17, 2021·JCO Oncology Practice·Jennifer Tran, Moshe C Ornstein
Jan 22, 2022·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·T E OsingaM van Kruchten

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

© 2022 Meta ULC. All rights reserved